An intricate regulation of Wbl A controlling production of silent tylosin analogues and abolishment of expressible nikkomycin

Genome sequencing has revealed that actinomycetes possess the potential to produce many more secondary metabolites than previously thought.The existing challenge is to devise efficient methods to activate these silent biosynthetic gene clusters(BGCs).In Streptomyces ansochromogenes,disruption of wbl A,a pleiotropic regulatory gene,activated the expression of cryptic tylosin analogues and abolished nikkomycin production simultaneously.Overexpressing pathway-specific regulatory genes tylR1 and tylR2 can also trigger the biosynthesis of silent tylosin analogues,in which TylR1 exerted its function via enhancing tylR2 expression.Bacterial one-hybrid system experiments unveiled that Wbl A directly inhibits the transcription of tylR1 and tylR2 to result in the silence of tylosin analogues BGC.Furthermore,Wbl A can activate the nikkomycin production through up-regulating the transcription of pleiotropic regulatory gene adp A.More interestingly,Adp A can activate san G(an activator gene in nikkomycin BGC)but repress wbl A.Our studies provide a valuable insight into the complex functions of pleiotropic regulators.

HCoV-NL63 N蛋白不同片段的表达纯化及血清学检测应用分析

将HCoV-NL63核衣壳蛋白N端（Np1~154aa）、C端（Cp141~306aa）基因片段克隆到原核表达载体pET30a（＋）上进行原核表达,制备相应的纯化蛋白Np、Cp蛋白,利用Np、Cp蛋白建立基于Western-Blot条带印迹的HCoV-NL63抗体检测法,并与基于全长N蛋白（Nf）的HCoV-NL63抗体检测法相平行筛查了50份成年体检血清。结果显示：50份成年体检血清中,采用Nf、Np、Cp分别检出25、27、36份HCoV-NL63抗体阳性血清,检出率分别为50%、54%、72%。不同N蛋白与血清反应抗体阳性谱存在差异,其中Np与Nf检出一致率为64%,Cp与Nf检出一致率为54%,而Np与Cp检出一致率为54%。本研究表明人冠状病毒NL63在我国人群中感染常见,N蛋白C端（Cp）检出率比全长N（Nf）及N端（Np）要高,Nf、Np、Cp在抗体检测上存在不一致性。这为HCoV-NL63血清学试剂研发及免疫学研究提供了依据与实验基础。